Company news
Intuitive Announces Over 10,000 Ion Robotic-Assisted Bronchoscopy Procedures Across Europe
Intuitive announced that clinicians across Europe have performed more than 10,000 robotic-assisted bronchoscopy procedures using the Ion endoluminal system since its CE mark in 2023, reflecting growing adoption and its potential to support earlier diagnosis and treatment of suspected lung cancer.
Published · Updated · Source: Surgical Robotics Technology · AI translation
IllustrationIntuitive said clinicians across Europe have used the Ion endoluminal system (Ion) to perform more than 10,000 robotic-assisted bronchoscopy procedures since its CE mark in 2023. Lung cancer is the leading cause of cancer death in Europe, with around 480,000 people diagnosed each year and up to 70% diagnosed at a late stage. When detected and treated early, five-year survival rates can reach up to 92%. Diagnosis often requires a biopsy of lung nodules, which are commonly found in tight spaces and narrow airways that may be hard to reach, meaning some patients with suspected lung cancer may undergo long periods of 'watchful waiting'. Ion has an ultra-thin, shape-sensing catheter designed to navigate deep into the lung, which can enable clinicians to access small, complex nodules and precisely position biopsy tools with stability. Dr. Oliver Wagner, Vice President and Medical Officer, Endoluminal Division at Intuitive, said behind every procedure is someone seeking answers about a potentially life-changing diagnosis, and through Ion the aim is to help clinicians replace that uncertainty with a clear answer earlier. In 2025, a Europe-first multi-centre clinical study demonstrated that Ion enables clinicians to safely and effectively reach and biopsy small nodules in difficult-to-access areas of the lung, with a high rate of diagnostic accuracy. Dirk Barten, Intuitive commercial president for Europe, said that as lung screening programmes expand across Europe, more potential lung cancers are being detected, and with Ion the company remains focused on supporting clinicians to give patients a clear diagnosis at the earliest possible stage. Ion is part of Intuitive's connected Ecosystem, and there are more than 1,000 Ion systems installed in hospitals globally, which were used by physicians to perform more than 140,000 lung biopsies across the globe in 2025. This information comes from the original source and was organized by AI.
Read the original sourceRelated news
- Hello Robotaxi Adjusts Organizational Structure, CEO Directly Oversees Model and Data Closed-Loop
- Medtronic's Hugo Surgical Robot Wins FDA Clearance for General Surgery
- Medtronic Wins FDA Clearance for Hugo RAS System in General Surgery
- GM Plans to Expand North American Factory Automation by 20% by 2028